BtHCROSS 1.75%

• Effective correction of moderate and deep wrinkles.

• Excellent balance between flexibility and structural support.

• Homogeneous tissue integration.

• Natural-looking results in highly mobile facial areas.

• High projection and correction capacity.

• Lasts up to 9 months.

• Very low endotoxin level (≤ 0.20 EU/mL).

• BDDE residues below 2 ppm.

• Manufactured in Europe to high quality standards.

• SARE Technology for greater clinical efficacy and durability.

Correction of moderate to deep facial wrinkles and folds. Particularly indicated for treating nasolabial folds, marionette lines and glabellar lines, providing support and harmony in dynamic areas of the face.

• Correction of deep folds. Effectively fills pronounced wrinkles and folds for a smoother, more rejuvenated appearance.

• Balanced structural support. Provides the firmness needed to correct tissue without compromising natural facial expression.

• Adaptation to dynamic areas. Its viscoelastic behaviour allows it to follow the face's natural movement, avoiding rigid or artificial-looking results.

• Homogeneous integration. Distributes evenly within the tissue to achieve harmonious and stable corrections.

• Optimised durability. Its enzymatic resistance and SARE Technology cross-linking promote longer clinical persistence and sustained results over time.

The amount of product to be injected will be determined by the specialist physician based on the area to be treated and the desired level of correction. After the first treatment session, several touch-up and/or repeat sessions may be required to achieve the desired correction. Treatment sessions should not be repeated at intervals of less than fifteen days.

SARE Technology

An innovative hyaluronic acid cross-linking method that delivers unique results through a highly homogeneous cross-linking process.

A proprietary combination of low- and high-molecular-weight hyaluronic acid that creates a polymer matrix with a low degree of modification.